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Impaired glucose tolerance as a risk 
factor for diabetes mellitus and 
hypertension in the Hong Kong Chinese 
population: a 5-year prospective study
Key Messages
1. The conversion rate to type 2 
diabetes at 5 years was 20% 
among Chinese subjects with 
impaired glucose tolerance, 
which was 8-fold that of 
sex- and age-matched normal 
controls.
2. Body mass index, fasting and 2-
hour plasma glucose predicted 
type 2 diabetes risk.
3. Cumulative prevalence of 
hypertension was consistently 
higher among subjects with 
impaired glucose tolerance than 
in those with normal glucose 
tolerance. Age, systolic blood 
pressure, and body mass index 
were predictive factors of 
incident hypertension in this 
study cohort.
4. Based on our cohort, the 
sensitivity and specificity 
of the Asian cut-off values 
for overweight and central 
obesity, recommended by the 
World Health Organization 
for identifying subjects at risk 
of diabetes and hypertension, 
appeared more appropriate 
for our population than values 
advocated for Caucasians.
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Introduction
Type 2 (non–insulin-dependent) diabetes mellitus (NIDDM) is associated 
with increased cardiovascular and all-cause mortality due to accelerated 
atherosclerosis. This increased cardiovascular risk, secondary to the underlying 
insulin resistance,1 probably precedes the onset of diabetes. Besides having a 
known pre-diabetic state, non-Chinese subjects with impaired glucose tolerance 
(IGT) have been reported to be at substantial risk of developing cardiovascular 
and cerebrovascular diseases.
 Well-designed randomised controlled studies have demonstrated the 
impact of lifestyle measures in individuals with IGT on progression to diabetes 
mellitus (DM).2,3 In order to study the incidence of, and predictive factors for, the 
development of type 2 DM in the local Hong Kong Chinese population with IGT, 
we prospectively followed up a cohort of 434 IGT subjects, and age- and sex-
matched normal controls, identified from a community-based population study 
in 1996 and 1997.
 According to the World Health Organization (WHO) 1998 criteria,4 diabetes 
is defined by a fasting plasma glucose (FPG) of ≥7 and/or a 2-hour plasma 
glucose of ≥11.1 mmol/L, and IGT by a 2-hour plasma glucose of ≥7.8 mmol/L 
but <11.1 mmol/L, in subjects with a FPG of <7 mmol/L.
Aims and objectives
The aims of this study were:
1. To determine the conversion rate of IGT to type 2 diabetes, as compared to 
normal subjects, within 5 years using the WHO4 (1985 and 1998) diagnostic 
criteria5;
2. To ascertain the prevalence and incidence of increased blood pressure (BP) 
[systolic ≥140 mm Hg and/or diastolic ≥90 mm Hg] as well as its associations 
with other cardiovascular risk factors at 5 years, among IGT as compared to 
normal subjects; and
3. To determine the cumulative incidence of both coronary heart disease and 
stroke among IGT as compared to normal subjects at 5 years.
Methods
This study was conducted from September 2000 to August 2002. Four hundred 
and thirty-four subjects with IGT were identified from a local community-based 
study,6 which began in January 1995. One major objective of the study was to 
assess the prevalence of type 2 diabetes and IGT in the local Chinese population. 
Baseline demographic, anthropometric, and biochemical data were collected. 
The IGT subjects were invited to participate in a 5-year follow-up study. An 
equal number of subjects with normal glucose tolerance (NGT), matched for age 
and sex, were also recruited from the same source to serve as controls. These 
NGT subjects and all subjects with IGT at baseline were invited to return for a 
face-to-face interview and repeat of the oral glucose tolerance test 5 years later.
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 Height was measured to the nearest 0.5 cm and weight 
to the nearest 0.1 kg. Participants were measured in socks, 
stockings, or bare feet and light street clothing (no coats or 
jerseys). Body mass index (BMI) was calculated as weight/
height2. Waist and hip circumferences were measured 
twice to the nearest 0.5 cm and the means were used for 
subsequent analyses. Waist circumference was measured 
half-way between the xiphisternum and the umbilicus while 
hip circumference was measured at the level of the greater 
trochanters.
 Blood pressure was measured sitting at rest, using 
fifth phase sounds with a mercury sphygmomanometer. 
Hypertensive subjects were defined as those taking anti-
hypertensive agents and those with untreated systolic BP of 
≥140 mm Hg and/or diastolic BP of ≥90 mm Hg.
Results
A total of 271 IGT (response rate, 62%) and 318 NGT 
(response rate, 73%) subjects returned at 5 years for re-study. 
The baseline characteristics of the non-participants (n=163) 
were not significantly different from the participants, except 
for higher triglyceride levels. Among the NGT subjects, 
those who returned were significantly older, having higher 
2-hour plasma glucose levels, systolic and diastolic BPs, 
and were more obese than those who did not.
 Anthropometric and biochemical data were analysed 
among the 271 IGT subjects and their age- and sex-
matched NGT controls (IGT+NGT: n=589). At baseline, 
IGT subjects as a group had significantly higher values 
for: BMI, waist circumference, waist-hip ratio, total 
blood cholesterol, low-density lipoprotein–cholesterol, 
triglyceride, fasting and 2-hour plasma glucose, systolic 
and diastolic BPs, but they had lower high-density 
lipoprotein–cholesterol levels.
 Of the 271 IGT subjects, 54 (19.9%; 95% confidence 
interval [CI], 15.1-24.7%) progressed to diabetes, 110 
(40.6%) still had IGT only, and 107 (39.5%) reverted to 
NGT. Of those in the NGT group, 8 (2.5%; 95% CI, 0.8-
2.8%) progressed to diabetes, 56 (17.6%) were reclassified 
as having IGT, and 254 (79.9%) as NGT. Using the WHO 
(1998) diagnostic criteria, the conversion rate to type 2 
diabetes among IGT and NGT subjects at 5 years was 20% 
(ie 4% per year on average) and 2.5% respectively (Table 
1). Each of the obesity markers at baseline predicted 
diabetes at 5 years (Table 2). Conversion to diabetes at 
the 5-year follow-up was predicted by baseline fasting 
glucose, post-load 2-hour plasma glucose and BMI, using 
the multiple logistic regression analysis forward stepwise 
method.
 Baseline hypertension prevalence among IGT subjects 
(30%) was significantly higher than in NGT subjects (22%) 
[P=0.016]. This difference in the cumulative prevalence of 
hypertension between IGT and NGT subjects remained at 5 
years (IGT 47% vs 38%, P=0.028). Among normotensive 
subjects at baseline, 18% (80/437) had developed 
hypertension within 5 years. Age, systolic BP, and BMI at 
baseline were significant predictors of incident hypertension 
at 5 years.
 Body mass index could serve as a screening tool for 
diabetes and hypertension, using lower Asian-specific cut-
Status at 
baseline
Status at 5 years Total
NGT IGT DM
NGT 254 (79.9%) 56 (17.6%) 8 (2.5%) [95% CI: 0.8-4.2%] 318 (100%)
IGT 107 (39.5%) 110 (40.6%) 54 (19.9%) [95% CI: 15.2-24.6%] 271 (100%)
Total 361 166 62 589
Table 1. Conversion to type 2 diabetes mellitus within 5 years (based on World Health Organization 1998 diagnostic criteria)*
* NGT denotes normal glucose tolerance, IGT impaired glucose tolerance, and DM diabetes mellitus
Anthropometric characteristic Glycaemic status at 5 years* F P value†
DM (n=62) Non-DM (n=527)
Waist circumference (cm)
Men 88.35±7.01 84.32±9.24 1.09 0.004
Women 84.31±8.66 76.82±8.72 0.01 <0.001
Body mass index (kg/m2)
Men 26.85±2.76 24.34±3.46 0.89 <0.001
Women 27.51±3.15 24.58±3.85 1.30 <0.001
Waist-hip ratio
Men 0.92±0.06 0.89±0.07 0.765 0.031
Women 0.86±0.06 0.81±0.07 0.772 0.002
Table 2. Anthropometric adiposity variables, stratified by gender and glycaemic status (as defined by the World Health 
Organization 1998 diagnostic criteria) at 5 years
* DM denotes diabetes mellitus 
† Independent Student’s t test
Wat et al
22      Hong Kong Med J Vol 14 No 3 Supplement 3 June 2008
off values for normality (23 kg/m2), in contrast to the higher 
general cut-off value (25 kg/m2) advocated by the WHO. 
Improved detection sensitivity (men: 90% vs 74%; women: 
100% vs 74%) and specificity (men: 65% vs 41%; women: 
63% vs 39%) were observed.
 Only 20 subjects in the IGT cohort developed 
cardiovascular and/or cerebrovascular end-points over the 
5-year study period. The numbers were too few for any 
conclusion to be drawn regarding the cardiovascular risk 
conferred by IGT.
Discussion
Our 5-year prospective study has demonstrated a 
significantly higher risk of progression to type 2 diabetes 
in Chinese subjects with IGT (20% over 5 years, or 4% per 
year, based on WHO 1998 diagnostic criteria), as compared 
to normal controls. Although differential response rates 
among IGT and NGT subjects might reflect their respective 
motivations for returning, the distribution of answers to 
questions administered at 5 years and at baseline showed a 
high degree of consistency.
 Individually, each of the parameters of overall or 
central obesity can independently predict diabetes. 
However, baseline FPG, 2-hour plasma glucose and 
BMI were significant predictors of diabetes at 5 years, 
after adjusting for other significant baseline variables. 
As waist circumference and waist-to-hip ratio are highly 
correlated (r=0.80; P<0.001), practicality comes into 
the picture. Since waist circumference is much simpler 
to determine than waist-to-hip ratio, both in day-to-day 
clinical practice or in epidemiological surveys, the former 
marker is preferred in assessing central obesity with regard 
to diabetes risk. Increasing BMI is associated with a higher 
risk of diabetes, hypertension, and other cardiovascular 
risks in both Caucasians and Asians. Our data using the 
development of diabetes or hypertension within 5 years 
as markers of obesity-related co-morbidities, suggest that 
lower cut-off values for both BMI (25-23 kg/m2) and waist 
circumference (men: 102-90 cm; women: 88-80 cm) be 
recommended for Asians, to improve detection sensitivity 
although it reduces specificity. As a screening tool for 
increased risk of developing diabetes or hypertension, BMI 
is more sensitive but less specific than waist circumference. 
Among subjects who were normotensive at baseline, age, 
systolic BP, and BMI were significant predictors of incident 
hypertension after 5 years.
 Our study has confirmed the increased risk of diabetes 
and hypertension associated with IGT. Current practice in 
its detection and management is probably inadequate and 
needs to be reviewed, taking into consideration factors 
predictive of the development of diabetes and hypertension 
identified in our population.
Conclusions
The 5-year cumulative diabetes conversion rate among IGT 
subjects in Hong Kong was eight times that of age- and 
sex-matched NGT controls. At baseline, IGT subjects as a 
group had more unfavourable cardiovascular risk factors than 
NGT subjects. We found that BMI, together with the fasting 
and 2-hour plasma glucose, predicted type 2 diabetes, and 
when used together with age and systolic BP, it could also 
predict hypertension. Using development of diabetes or 
hypertension at 5 years as markers of obesity-related co-
morbidities, our data suggest that lowering BMI and waist 
circumference cut-off levels recommended for Asians, can 
improve the detection sensitivity and reduce the specificity 
for these diseases. Body mass index is more sensitive as a 
screening tool than waist circumference.
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